July 22, 2014

Where to Spend Your Healthcare Investment Dollars

In a blog entry written over the summer, I expressed the view that the next 5-10 years will present tremendous transactional opportunities in the life sciences/health care industry. Nothing has happened to dampen that view. In fact, President Obama’s reelection, which means that the Patient Protection and Affordable Care Act is here to stay and will be fully implemented over the next few years, and our ongoing deficit reduction concerns, mandate that efficiency, cost control and strategic ways to provide better quality healthcare will be at center stage. So let’s focus in on some investment opportunities that may be interesting.

For those willing to tackle regulatory and reimbursement hurdles, there should be many opportunities in the provider world. This could take the form of hospital mergers and consolidations, spin-off of various medical and lab services that have been provided at hospitals and physician practice acquisitions by hospitals or other service companies. With the pressure to reduce costs, and  incentives (or penalties) being established to encourage providers to meet standards of quality and efficiency, the old way of doing things – multiple providers providing the same services – simply cannot survive. And if we move to providers being paid on a capitation basis, as is likely to be the case over time, only the most efficient and effective providers will survive.

Investments in healthcare technology is also an area to focus on. As with the technology investments of the past, timing (or acceptance in the marketplace) will be an important consideration. But it appears that the opportunities are ripening in this space. It has been reported that venture financings globally in digital health have increased almost 500% in the last three years. The key drivers to lower cost and more effective healthcare include the gathering, analyzing and sharing of more healthcare information quickly and broadly to facilitate preventative medical steps and overall quality treatment with less error. As data technology and analysis improves, becomes less expensive and is mandated or otherwise widely accepted, companies in this industry will be very attractive.

While adopting  new practice and business paradigms is not easy, takes time and poses cultural issues, I would bet on the long term health of those institutions and companies that start moving in that direction. And this should present robust opportunities for strategic and financial investors.

©2014 Drinker Biddle & Reath LLP. All Rights Reserved

About the Author


Neil K. Haimm is a partner in the Corporate and Securities Practice Group and one of the managing partners of the firm. He has been a corporate lawyer for more than 30 years. Neil's practice focuses primarily on acquisitions and divestitures, joint ventures and other strategic transactions and venture capital and private equity investments.

Neil publishes in the Life Sciences Now blog.


Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is  intended to be  a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.

The National Law Review - National Law Forum LLC 4700 Gilbert Ave. Suite 47 #230 Western Springs, IL 60558  Telephone  (708) 357-3317 If you would ike to contact us via email please click here.